Biote Companies Are a Buyer's Market

There are cycles of capital influences that dramatically affect the valuations of biote companies. Most of the stuff we bring in is, i pre clinical, its pre clinical, or in the very early phases of bote development. The prices are a lot r at the late stage these days. There aren't that many of them, and the prices are high when they are. And even the prices are pretty high for pre clinical. Causetey, were a completely different market. It's like you and maybe three other people maybeyso there're a couple of things. When capital flows out of the bite sector, am then partner becomes one of the waves in which capital can flow into